Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate the Efficacy and Safety of Co-administration of AD-2281 and AD-2282
Sponsor: Addpharma Inc.
Summary
The purpose of this study is to evaluate the efficacy and safetyof co-administration of AD-2281 and AD-2282 in patients with Primary Hypercholesterolemia
Official title: A Randomized, Double-blind, Active-controlled, Multi-center, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of Combined Administration of AD-2281 and AD-2282 in Patients With Primary Hypercholesterolemia.
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
129
Start Date
2025-02-03
Completion Date
2025-05-30
Last Updated
2026-08-27
Healthy Volunteers
No
Conditions
Interventions
AD-2281
PO, Once daily, 8weeks
AD-2282
PO, Once daily, 8weeks
Placebo of AD-2282
PO, Once daily, 8weeks
Locations (1)
Severance Hospital
Seoul, Seoul, South Korea